Author

E. C. F. Yeo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Organism:human· 1 Assay:imaging· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

B. L. Gliddon· 1 shared D. S. Ziegler· 1 shared J. Nowicki· 1 shared K. Sedivakova· 1 shared L. M. Ebert· 1 shared M. N. Tea· 1 shared M. P. Brown· 1 shared N. L. Wittwer· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

B. L. Gliddon

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivMay 1, 2022

GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma

T. Gargett, L. M. Ebert, N. T. H. Truong…·M. P. Brown

This study demonstrates that GD2-targeting CAR-T cells, enhanced with IL-15 transgene expression, effectively control glioblastoma growth in a preclinical model and are clinically feasible.

DOI 10.1136/jitc-2022-005187

humanflow cytometry

𝕏 PostBluesky